News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Bank of America Merrill Lynch HealthCare Conference

BOULDER, Colo., May 5, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas.  The public is welcome to participate in the conferences through a webcast on the Array BioPharma website. 

 


Event:                         Bank of America Merrill Lynch Healthcare Conference

Date:                           Tuesday, May 10, 2016

Time:                          3:00 p.m. PDT

Location:                    Encore at the Wynn, Las Vegas, NV

Webcast:                    investor.arraybiopharma.com

 

About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

 

CONTACT:

Tricia Haugeto


Array BioPharma Inc


303-386-1193


thaugeto@arraybiopharma.com

 

Array BioPharma.

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-bank-of-america-merrill-lynch-healthcare-conference-300264159.html

SOURCE Array BioPharma Inc.